Skip navigation, view page content

OSU masthead and toolbar

The Ohio State University
www.osu.edu
  1. Help
  2. Campus map
  3. Find people
  4. Webmail


Research Unit on Pediatric Psychopharmacology    
Research Unit on Pediatric Psychopharmacology

Research Unit on Pediatric Psychopharmacology

 

Medication and Alternative Studies for Children and Adolescents
with Attention Deficit Hyperactivity Disorder (ADHD)

Our list of clinical studies provides contact information and links to basic participation requirements. Please check this page frequently. New studies will be posted prior to subject recruiting.

Alternative ADHD Studies || Medication ADHD Studies || Completed ADHD Studies


Current Alternative ADHD Studies

Study of Zinc Absorption (now accepting participants)

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.


Current ADHD Medication Studies

 

 


Completed Studies

Zinc Supplementation and Medication for ADHD Ages 6-14

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Study of Daytrana in ADHD for children 6-12

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Study of a Patch for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Previously Treated with Extended Release Methylphenidate Product

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

8th Nerve Stimulation as Treatment for Children with ADHD Ages 6-12

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

A Study of Atomoxetine (Strattera™) for Children and Adolescents with Autism, Asperger's Syndrome, or other Pervasive Developmental Disorder (PDD) and Signs of Attention-Deficit/Hyperactivity Disorder (ADHD)

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Comparison of MethyPatch® and Concerta® in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Study of Mecamylamine, a Non-stimulant Investigational Medication, as Treatment for ADHD Age 6 - 17

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Study of Acetyl-L-Carnitine, a Non-stimulant Investigational Medication in Children with ADHD Ages 5 - 12

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Ritalin LA® in Adolescent Females with ADHD

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Atomoxetine (Strattera™) Long Term Study for Children with ADHD and Internalizing (Depression, Anxiety) Symptoms

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

Study of a Nutritional Supplement (SH90011 L-Carnitine Compound) in Children with ADHD

For more information, please contact Ashley Reno, Study Coordinator, at 614-688-8214 or reno.37@osu.edu.

 

^Back to top